Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Geriatrics
Metadata
Title
The use of Goal Attainment Scaling in a community health promotion initiative with seniors
Publication date
01-12-2007
Published in
BMC Geriatrics / Issue 1/2007
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/1471-2318-7-16

Other articles of this Issue 1/2007

BMC Geriatrics 1/2007 Go to the issue

Study protocol

Passive movement therapy in patients with moderate to severe paratonia; study protocol of a randomised clinical trial (ISRCTN43069940)

Study protocol

The Newcastle 85+ study: biological, clinical and psychosocial factors associated with healthy ageing: study protocol

Research article

A snapshot of the prevalence of physical activity amongst older, community dwelling people in Victoria, Australia: patterns across the 'young-old' and 'old-old'

Study protocol

A perturbation-based balance training program for older adults: study protocol for a randomised controlled trial

Research article

Physicians' attitudes about artificial feeding in older patients with severe cognitive impairment in Japan: a qualitative study

Correspondence

Ten commandments for the future of ageing research in the UK: a vision for action

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits